Literature DB >> 8413248

A cis element required for induction of the interleukin 2 enhancer by human T-cell leukemia virus type I binds a novel Tax-inducible nuclear protein.

M Li1, M Siekevitz.   

Abstract

The 40-kDa nuclear protein Tax encoded by human T-cell leukemia virus type I (HTLV-I) can transcriptionally activate the interleukin 2 (IL-2) enhancer even in the presence of the immunosuppressant cyclosporin A, which inhibits the activation of the IL-2 enhancer by T-cell mitogens. We have identified a Tax-responsive element (TxRE) from -164 to -145 bp in the IL-2 enhancer which is sufficient to confer Tax responsiveness. A 45-kDa nuclear protein (TxRE-binding factor [TxREF]), present in Tax-expressing Jurkat cell lines but not in Jurkat cells without Tax, specifically interacts with the 5' TxRE sequence from -164 to -154. Deletion or mutation of this 5' TxRE sequence removes the binding of TxREF in vitro and dramatically reduces Tax activity in vivo. In addition, this site is responsible for the cyclosporin A-resistant expression of the IL-2 enhancer in the presence of Tax. Although the TxREF binding site contains an NF-kappa B like motif, UV cross-linking studies as well as gel retardation analysis reveal that TxREF is distinct from NF-kappa B. These results demonstrate that TxREF is a novel Tax-inducible DNA-binding protein and that TxRE plays a crucial role in mediating Tax-induced IL-2 gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413248      PMCID: PMC364708          DOI: 10.1128/mcb.13.10.6490-6500.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.

Authors:  M Siekevitz; M B Feinberg; N Holbrook; F Wong-Staal; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  Characterization of antigen receptor response elements within the interleukin-2 enhancer.

Authors:  D B Durand; J P Shaw; M R Bush; R E Replogle; R Belagaje; G R Crabtree
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

3.  A transgenic mouse model for human neurofibromatosis.

Authors:  S H Hinrichs; M Nerenberg; R K Reynolds; G Khoury; G Jay
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

4.  Fiber pathways of cortical areas mediating smooth pursuit eye movements in monkeys.

Authors:  R J Tusa; L G Ungerleider
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

5.  T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.

Authors:  C H June; J A Ledbetter; M M Gillespie; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

6.  Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression.

Authors:  J K Nyborg; W S Dynan; I S Chen; W Wachsman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

7.  The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.

Authors:  E Böhnlein; J W Lowenthal; M Siekevitz; D W Ballard; B R Franza; W C Greene
Journal:  Cell       Date:  1988-06-03       Impact factor: 41.582

8.  HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor.

Authors:  K Leung; G J Nabel
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

9.  Expression of TGF-beta gene in adult T cell leukemia.

Authors:  Y Niitsu; Y Urushizaki; Y Koshida; K Terui; K Mahara; Y Kohgo; I Urushizaki
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

10.  A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor.

Authors:  D B Durand; M R Bush; J G Morgan; A Weiss; G R Crabtree
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  5 in total

1.  Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.

Authors:  L Good; S B Maggirwar; S C Sun
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

2.  Requirements for interleukin 2 promoter transactivation by the Tax protein of human T-cell leukemia virus type 1.

Authors:  V E Curtiss; R Smilde; K L McGuire
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

3.  Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax.

Authors:  S R Himes; R Katsikeros; M F Shannon
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

4.  RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.

Authors:  J H Lai; G Horvath; J Subleski; J Bruder; P Ghosh; T H Tan
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

Review 5.  Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia.

Authors:  Hiba El Hajj; Ali Bazarbachi
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.